VSMCs protect the vessels from proteolytic injury caused by atherosclerosis by expressing high levels of anti-plasmin proteins and endocytic LDL-receptor-related protein-1 (LRP-1), which is able to capture aggregated LDL and plasmin–antiplasmin complexes [215]. This evidence concerns the gene LRP1 and atherosclerosis.